Pharmacological activities of 1,1-diethyl-2-methyl-3-diphenylmethylenepyrrolidinium bromide (pyrodifenium bromide).
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001965:Bromides / Q000494:pharmacology* / Q000633:toxicity; D002415:Cats; D002490:Central Nervous System; D002606:Charcoal / Q000494:pharmacology; D004285:Dogs; D004569:Electroencephalography; D005260:Female; D005725:Ganglia, Autonomic / Q000187:drug effects; D005753:Gastric Mucosa / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009055:Mouth / Q000187:drug effects; D009388:Neostigmine; D009469:Neuromuscular Junction / Q000187:drug effects; D011680:Pupil / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology*; D012018:Reflex / Q000187:drug effects; D012472:Salivation / Q000187:drug effects; D013276:Stomach Ulcer; D013312:Stress, Physiological; D014566:Urogenital System / Q000187:drug effects
D001965:Bromides; D006584:Hexamethonium Compounds; D011759:Pyrrolidines; D002606:Charcoal; D009388:Neostigmine; D001285:Atropine; D000109:Acetylcholine